Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy.

Aghbash, Parisa Shiri; Rasizadeh, Reyhaneh; Yari, Amir Hossein; Lahouti, Shiva; MotieGhader, Habib; Nahand, Javid Sadri; Entezari-Maleki, Taher; Baghi, Hossein Bannazadeh.

Afiliação

Aghbash PS; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Rasizadeh R; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Yari AH; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Lahouti S; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
MotieGhader H; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Nahand JS; Department of Biology, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
Entezari-Maleki T; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Baghi HB; Department of Biology, Tabriz Branch, Islamic Azad University, Tabriz, Iran.

Anticancer Agents Med Chem ; 23(18): 2008-2026, 2023.

Article em En | MEDLINE | ID: mdl-37497707